Cargando…
A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer
SIMPLE SUMMARY: Patients with high-risk prostate cancer are usually treated with combination of radiotherapy and androgen deprivation therapy. However, there has been long strides of advancements in the domain of radiotherapy and systemic therapy in the last decade. Similarly, there has been signifi...
Autores principales: | Burgess, Laura, Roy, Soumyajit, Morgan, Scott, Malone, Shawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428221/ https://www.ncbi.nlm.nih.gov/pubmed/34503067 http://dx.doi.org/10.3390/cancers13174257 |
Ejemplares similares
-
Implications of local failure on overall prognosis in aggressive prostate cancer
por: Mula-Hussain, Layth, et al.
Publicado: (2020) -
Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies
por: Juloori, Aditya, et al.
Publicado: (2016) -
Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer
por: Roy, Soumyajit, et al.
Publicado: (2023) -
Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm
por: Gulley, James L., et al.
Publicado: (2015) -
Novel therapies are changing treatment paradigms in metastatic prostate cancer
por: Powers, Eric, et al.
Publicado: (2020)